Insulin glargine and lixisenatide Subcutaneous and Palonosetron injection
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Palonosetron injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: palonosetron
Brand name: Aloxi
Synonyms: Palonosetron (injection), Palonosetron
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Palonosetron Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Palynziq
- Insulin glargine and lixisenatide Subcutaneous-Pamabrom
- Insulin glargine and lixisenatide Subcutaneous-Pamelor
- Insulin glargine and lixisenatide Subcutaneous-Pamidronate
- Insulin glargine and lixisenatide Subcutaneous-Pamidronate Disodium
- Palonosetron injection-Insulin glargine, recombinant Subcutaneous
- Palonosetron injection-Insulin glulisine
- Palonosetron injection-Insulin Glulisine (Cartridges and Pens)
- Palonosetron injection-Insulin Glulisine (Vials)
- Palonosetron injection-Insulin glulisine Subcutaneous
- Palonosetron injection-Insulin human inhaled Inhalation